Nancy P Ip

Title: Nancy P. Ip: A Pioneer in Neurotrophic Factor Research

Introduction

Nancy P. Ip is a distinguished inventor based in Hong Kong, CN. She has made significant contributions to the field of neurotrophic factors, which are essential for the growth, survival, and differentiation of neurons. Her innovative work has led to the development of novel therapeutic approaches for neurological disorders.

Latest Patents

Nancy P. Ip holds a patent for "Multitrophic and multifunctional chimeric neurotrophic factors." This invention relates to chimeric neurotrophic factors that comprise at least a portion of a naturally occurring cellular factor and a portion of at least one other molecule. The resulting chimeric molecule exhibits neurotrophic activity. The invention is based on the discovery that chimeric molecules comprising portions of both NGF and BDNF are likely to possess neurotrophic activity, often exhibiting a broader spectrum of activity than either parent molecule. Additionally, these chimeric molecules may retain neurotrophic activity and, in some cases, demonstrate more potent effects than the parent factors. The advantages of these chimeric neurotrophic factors include the ability to provide the activity of two neurotrophic factors in a single molecule or to act as superagonists of an endogenous neurotrophic factor, enhancing biological responses at lower doses. Nancy P. Ip has 1 patent to her name.

Career Highlights

Nancy P. Ip is currently associated with Regeneron Pharmaceuticals, Inc., where she continues her groundbreaking research. Her work has significantly advanced the understanding of neurotrophic factors and their potential applications in treating various neurological conditions.

Collaborations

Throughout her career, Nancy has collaborated with notable scientists, including Eric M. Shooter and Ulrich Suter. These collaborations have further enriched her research and contributed to the advancement of neurotrophic factor studies.

Conclusion

Nancy P. Ip is a leading figure in the field of neurotrophic factor research, with her innovative patents paving the way for new therapeutic strategies. Her contributions continue to impact the scientific community and hold promise for future advancements in neuroscience.